Axsome Therapeutics, Inc. (AXSM)
199.02
-7.25
(-3.51%)
USD |
NASDAQ |
Aug 28, 16:00
199.30
+0.28
(+0.14%)
After-Hours: 20:00
Axsome Therapeutics Cash from Operations (Quarterly) : -32.95M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.95M |
| March 31, 2026 | -20.70M |
| December 31, 2025 | -18.65M |
| September 30, 2025 | 1.046M |
| June 30, 2025 | -32.42M |
| March 31, 2025 | -43.38M |
| December 31, 2024 | -26.20M |
| September 30, 2024 | -18.63M |
| June 30, 2024 | -30.11M |
| March 31, 2024 | -53.47M |
| December 31, 2023 | -30.36M |
| September 30, 2023 | -53.55M |
| June 30, 2023 | -55.35M |
| March 31, 2023 | -5.821M |
| December 31, 2022 | -27.56M |
| September 30, 2022 | -22.76M |
| June 30, 2022 | -33.54M |
| March 31, 2022 | -32.65M |
| December 31, 2021 | -29.15M |
| September 30, 2021 | -26.78M |
| June 30, 2021 | -25.39M |
| Date | Value |
|---|---|
| March 31, 2021 | -27.22M |
| December 31, 2020 | -20.55M |
| September 30, 2020 | -15.73M |
| June 30, 2020 | -18.90M |
| March 31, 2020 | -23.27M |
| December 31, 2019 | -17.57M |
| September 30, 2019 | -10.63M |
| June 30, 2019 | -8.682M |
| March 31, 2019 | -9.499M |
| December 31, 2018 | -9.794M |
| September 30, 2018 | -5.912M |
| June 30, 2018 | -7.667M |
| March 31, 2018 | -6.680M |
| December 31, 2017 | -6.291M |
| September 30, 2017 | -6.447M |
| June 30, 2017 | -7.097M |
| March 31, 2017 | -6.636M |
| December 31, 2016 | -7.217M |
| September 30, 2016 | -4.802M |
| June 30, 2016 | -5.315M |
| March 31, 2016 | -3.948M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly & Co. | 10.69B |
| Liquidia Corp. | 80.24M |
| Filana Therapeutics, Inc. | -3.855M |
| CorMedix, Inc. | 86.06M |
| Eloxx Pharmaceuticals, Inc. | -4.789M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.45M |
| Cash from Financing (Quarterly) | 48.15M |
| Free Cash Flow | -71.96M |
| Free Cash Flow Per Share (Quarterly) | -0.6448 |
| Free Cash Flow to Equity (Quarterly) | -38.20M |
| Free Cash Flow to Firm (Quarterly) | -30.19M |
| Free Cash Flow Yield | -0.71% |